RE: Valuation2 Aug 2020 15:05
Woodstock ,
As we all know , funding will be needed to advance the COPD and Covid trials to the next level .
That said , I will reiterate my point of view on the subject ...I believe that we will get a partnership announcement and in that partnership announcement we should see the partner taking a significant stake in Synairgen 15-30 % imo ...
The proceeds from these new shares will give Synairgen the funds to do the P3 trial ´ on their own ´ or allow them to advance other possibilities with SNG001...
There will of course be dilution to existing shareholders but not many will mind being diluted at the ´ negotiated ´ SP for the partner ...
WIn win situation for everyone, imv